| MEN1 mutations mediate clinical resistance to menin inhibition F Perner, EM Stein, DV Wenge, S Singh, J Kim, A Apazidis, ... Nature 615 (7954), 913-919, 2023 | 73 | 2023 |
| Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia TM Robinson, RL Bowman, S Persaud, Y Liu, R Neigenfind, Q Gao, ... Science Advances 9 (38), eadg0488, 2023 | 14 | 2023 |
| The second generation type II JAK2 inhibitor, AJ1-10502, demonstrates enhanced selectivity, improved therapeutic efficacy and reduced mutant cell fraction compared to type I … S Rai, J Stetka, M Usart, H Hao-Shen, Y Park, R Houston, ... Blood 140 (Supplement 1), 6722-6723, 2022 | 9 | 2022 |
| Single cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia T Robinson, RL Bowman, S Persaud, Y Liu, Q Gao, JP Zhang, X Sun, ... Blood 140 (Supplement 1), 2275-2277, 2022 | 5 | 2022 |
| Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer AO Olukoya, H Stires, S Bahnassy, S Persaud, Y Guerra, S Ranjit, S Ma, ... Journal of the Endocrine Society 7 (10), bvad117, 2023 | 4 | 2023 |
| Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer H Stires, AO Olukoya, S Ma, S Persaud, Y Guerra, MI Cruz, C Benitez, ... bioRxiv, 2020.07. 30.227561, 2020 | 3 | 2020 |
| Glutamate Transport Proteins and Metabolic Enzymes are Poor Prognostic Factors in Invasive Lobular Carcinoma TA Young, S Bahnassy, TC Abalum, EA Pope, AT Rivera, AI Fernandez, ... bioRxiv, 2024.09. 29.615681, 2024 | | 2024 |
| THU495 Glutamate Metabolic Enzymes GLUD1/2 And GPX4 Are Associated with Tumor Size In Black Women With Invasive Lobular Breast Cancer T Young, TC Abalum, N Hodgins, S Persaud, AI Fernandez, AO Olukoya, ... Journal of the Endocrine Society 7 (Supplement_1), bvad114. 2123, 2023 | | 2023 |
| Erythroid and Megakaryocytic Differentiation Program in JAK2-Mutated Acute Myeloid Leukemia with or without Antecedent Myeloproliferative Neoplasm Y Liu, S Sethi, R Koche, Q Gao, D Dilip, JL Glass, PK Galera, S Persaud, ... Blood 140 (Supplement 1), 9160-9162, 2022 | | 2022 |
| OR16-5 Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer S Bahnassy, C Benitez, MI Cruz, Y Guerra, S Ma, S Persaud, G Raj, ... Journal of the Endocrine Society 6 (Suppl 1), A880, 2022 | | 2022 |
| SAT-119 Targeting Glutamate Metabolism and Signaling in ER+, Endocrine Therapy-Resistant Breast Cancer AO Olukoya, H Stires, Y Guerra, S Persaud, S Ma, GV Raj, RB Riggins Journal of the Endocrine Society 4 (Supplement_1), SAT-119, 2020 | | 2020 |
